Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hydrogen Inhalation Ameliorates Ventilator-Induced Lung Injury

By HospiMedica International staff writers
Posted on 13 Jan 2011
A new study has found that inhaled hydrogen gas effectively reduces ventilator-induced lung injury (VILI)-associated inflammatory responses, at both a local and systemic level. More...


Researchers at the University of Pittsburgh Medical Center (UPMC; PA, USA), the Taiwanese National Yang-Ming University School of Medicine (Taipei), and other institutions hypothesized that inhaled hydrogen therapy could ameliorate VILI, due to its antioxidant, anti-inflammatory, and antiapoptotic properties. To test the hypothesis, VILI was generated in male mice by performing a tracheostomy and placing the mice on mechanical ventilation (MV).The mice were randomly assigned to treatment groups and subjected to VILI with delivery of either 2% nitrogen or 2% hydrogen in air. Sham animals were given same gas treatments for two hours. The effects of VILI induced by less invasive and longer exposure to MV were also investigated.

The results showed that ventilation at 30 mL/kg with 2% nitrogen in air for 2 hours resulted in deterioration of lung function, increased lung edema, and infiltration of inflammatory cells. In contrast, ventilation with 2% hydrogen in air significantly ameliorated these acute lung injuries. Hydrogen treatment also significantly inhibited upregulation of mRNA proinflammatory mediators and induced antiapoptotic genes. In the lungs treated with hydrogen, there was less malondialdehyde compared with lungs treated with nitrogen. Similarly, longer exposure to MV within lower tidal volume caused lung injury, including bronchial epithelial apoptosis; hydrogen improved gas exchange and reduced VILI-induced apoptosis. The study was published on December 25, 2010, in Critical Care.

"Although extensive studies on toxicity and safety are needed, hydrogen treatment of ventilated patients may be clinically feasible and would be easy to incorporate without alteration of interventional and surgical procedures,” concluded lead author Chien-Sheng Huang, MD, of the UPMC department of cardiothoracic surgery, and colleagues.

Hydrogen is a stable molecule and does not react with other therapeutic medical gases at room temperature; thus, it may be administered as a combined gas with other therapeutic gases, or with inhaled anesthesia agents. Inhaled hydrogen gas has been safely utilized for treatment of decompression syndrome in divers, suggesting that hydrogen can be safely administered to patients.

Related Links:
University of Pittsburgh Medical Center
Taiwan National Yang-Ming University School of Medicine


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.